Monoclonal Antibodies in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
411-414
Author(s):
Barbara Gatto
An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2377-2389
Author(s):
O.M. Zack Howard and Carole L. Galligan
Pathogenesis of HIV-Associated Non-Hodgkin Lymphoma
Journal:
Current HIV Research
Volume:
2
Page:
215-221
Author(s):
Deirdre Killebrew and Bruce Shiramizu
The Role of Protein Kinase C-alpha (PKC-α) in Cancer and its Modulation by the Novel PKC-α-Specific Inhibitor Aprinocarsen
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1923-1936
Author(s):
A- R. Hanauske, Karen Sundell and Michael Lahn
Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1767-1784
Author(s):
M. Cetkovic-Cvrlje and H. E. Tibbles
Immunotoxins and Other Conjugates: Pre-clinical Studies
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
563-583
Author(s):
A. Bolognesi and L. Polito
Targeting Translation for Treatment of Cancer - A Novel Role for IRES?
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
299-311
Author(s):
Martin Holcik
New Molecules and Strategies in the Field of Anticancer Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
247-262
Author(s):
Marchini S., D'Incalci M. and Broggini M.
Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
125-146
Author(s):
Johann Hofmann
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello